Nearly all study participants exhibited a positive antibody response after completing a two-dose Pfizer/BioNTech or Moderna vaccine series.
-
-
Novavax’s Covid-19 vaccine is now available in the United States for use as a first booster dose for people 18 and older.
-
Moderna and Pfizer both sought FDA emergency use authorization for their updated Covid-19 boosters for younger people in recent days. Moderna is seeking authorization for children as young as 6 years and Pfizer for children ages 5 through 11.
-
Moderna outlined specific instances where the company claims Pfizer’s infringed on its patents, saying the company moved foward with “a vaccine that has the same exact mRNA chemical modification to its vaccine as Spikevax. Moderna scientists began developing this chemical modification that avoids provoking an undesirable immune response when mRNA is introduced into the body in 2010 and were the first to validate it in human trials in 2015.”
-
LAX holds pop-up vaccine clinic amidst the holiday travel season.
-
COVID-19 booster shot recommended by CDC with new Omicron variant.
-
Booster Shots for Moderna and Johnson & Johnson Vaccines Are Said To Be Available By Tuesday For Riverside County
-
The daily pace of new Covid-19 vaccinations in the United States is the lowest it has been since the Centers for Disease Control and Prevention started tracking it in mid-January, data shows.
